Milestone Scientific (NYSE:MLSS) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS) in a report released on Friday morning. The firm issued a hold rating on the stock.

Separately, Benchmark reiterated a “speculative buy” rating and set a $1.25 price target on shares of Milestone Scientific in a research report on Wednesday, November 20th.

Milestone Scientific Price Performance

Shares of Milestone Scientific stock opened at $0.93 on Friday. Milestone Scientific has a 1 year low of $0.52 and a 1 year high of $1.10. The stock has a market cap of $72.05 million, a PE ratio of -13.21 and a beta of 1.10. The firm has a fifty day moving average price of $0.81 and a 200 day moving average price of $0.86.

Insider Buying and Selling at Milestone Scientific

In other Milestone Scientific news, Director Leonard Osser sold 107,984 shares of the firm’s stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total value of $100,425.12. Following the transaction, the director now owns 4,606,882 shares in the company, valued at approximately $4,284,400.26. This trade represents a 2.29 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Over the last three months, insiders have sold 128,193 shares of company stock valued at $116,234. Company insiders own 24.75% of the company’s stock.

Institutional Investors Weigh In On Milestone Scientific

A number of hedge funds have recently modified their holdings of MLSS. Geode Capital Management LLC grew its stake in Milestone Scientific by 6.4% during the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after acquiring an additional 31,572 shares in the last quarter. Y Intercept Hong Kong Ltd purchased a new position in Milestone Scientific in the 3rd quarter worth approximately $48,000. Finally, World Investment Advisors LLC acquired a new position in shares of Milestone Scientific during the 3rd quarter worth approximately $91,000. 5.79% of the stock is currently owned by institutional investors and hedge funds.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.